Fw: ANALYSIS-Vertex takes early rounds of hep C bout with Merck - AlertNet

By Guest guest
September 29, 2011 in Health, Medicine and Natural Healing 11

Followers 0

Recommended Posts

Guest guest

Posted September 29, 2011

- Report
- Share

Posted September 29, 2011

This is an article comparing the two new drugs for Hep C. It is also about the stock but does give other info that is interesting. I was not aware that one drug had better SVR rates than the other in clinical trials. If you are planning to treat, you might want to read it. Subject: ANALYSIS-Vertex takes early rounds of hep C bout with Merck - AlertNet

http://www.trust.org/alertnet/news/analysis-vertex-takes-early-rounds-of-hep-c-bout-with-merck#.ToVUk3EfC-0.email---

Quote

Link to comment

Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

× Pasted as rich text. Paste as plain text instead

Only 75 emoji are allowed.

× Your link has been automatically embedded. Display as a link instead

× Your previous content has been restored. Clear editor

× You cannot paste images directly. Upload or insert images from URL.